Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
Frontiers in Oncology|January 19, 2024
Dietary intervention for tertiary prevention in head and neck squamous cell carcinoma survivors: clinical and translational results of a randomized phase II trialStefano Cavalieri, Eleonora Bruno, Mara Serena Serafini, et al.
Oncogene|September 21, 2004
Gene expression profiling of advanced ovarian cancer: characterization of a molecular signature involving fibroblast growth factor 2Loris De Cecco, Luigi Marchionni, Manuela Gariboldi, et al.
Cancer Research|January 8, 2014
Transcriptional profiling of melanoma sentinel nodes identify patients with poor outcome and reveal an association of CD30(+) T lymphocytes with progressionViviana Vallacchi, Elisabetta Vergani, Chiara Camisaschi, et al.
JCO Precision Oncology|November 5, 2021
Clinical Validity of a Prognostic Gene Expression Cluster-Based Model in Human Papillomavirus-Positive Oropharyngeal CarcinomaStefano Cavalieri, Mara S Serafini, Andrea Carenzo, et al.
Cells|October 14, 2022
An Inflammatory Signature to Predict the Clinical Benefit of First-Line Cetuximab Plus Platinum-Based Chemotherapy in Recurrent/Metastatic Head and Neck CancerStefano Cavalieri, Mara Serena Serafini, Andrea Carenzo, et al.
The Lancet. Oncology|July 13, 2016
Development and validation of a microRNA-based signature (MiROvaR) to predict early relapse or progression of epithelial ovarian cancer: a cohort studyMarina Bagnoli, Silvana Canevari, Daniela Califano, et al.
Oncotarget|September 23, 2016
Biomarker analysis of the MITO2 phase III trial of first-line treatment in ovarian cancer: predictive value of DNA-PK and phosphorylated ACCFrancesco Perrone, Gustavo Baldassarre, Stefano Indraccolo, et al.
Head & Neck|October 27, 2020
Development of a multiomics database for personalized prognostic forecasting in head and neck cancer: The Big Data to Decide EU ProjectStefano Cavalieri, Loris De Cecco, Ruud H Brakenhoff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2018
Anti-Folate Receptor Alpha-Directed Antibody Therapies Restrict the Growth of Triple-negative Breast CancerAnthony Cheung, James Opzoomer, Kristina M Ilieva, et al.
Nature Communications|July 25, 2023
Safety and anti-tumour activity of the IgE antibody MOv18 in patients with advanced solid tumours expressing folate receptor-alpha: a phase I trialJames Spicer, Bristi Basu, Ana Montes, et al.
Pageof 12